What are GeneDx Holdings's profit margins?

GeneDx Holdings (WGS) runs a 69.6% gross margin and a -14.9% operating margin, with a -17.6% net margin.

Where do GeneDx Holdings's ratios come from?

Every ratio is computed from GeneDx Holdings's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

GeneDx Holdings WGS Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Gross margin	69.6%-0.2pp	69.7%+0.1pp	69.6%+2.5pp	67.2%+1.9pp	65.3%+1.6pp
Efficiency
Asset turnover	0.9×0.0×	0.9×0.0×	0.9×0.0×	0.8×+0.1×	0.8×+0.1×
Inventory turnover	10.8×+0.3×	10.5×-0.9×	11.4×+0.8×	10.7×+1.2×	9.4×-2.0×
Liquidity
Current ratio	3.1×+0.6×	2.5×-0.2×	2.7×-0.2×	2.9×-0.4×	3.2×-0.4×
Quick ratio	2.9×+0.6×	2.3×-0.3×	2.6×-0.1×	2.7×-0.4×	3.1×-0.4×
Cash ratio	1.1×+0.1×	1×-0.1×	1.1×+0.1×	1.1×-0.4×	1.4×-0.1×
Leverage
Debt-to-equity	0.4×0.0×	0.4×+0.2×	0.2×0.0×	0.2×0.0×	0.2×-0.3×
Debt-to-assets	0.2×0.0×	0.2×+0.1×	0.1×0.0×	0.1×0.0×	0.1×-0.2×
Per Share
Book value per share	$8.66-19.5%	$10.76+6.0%	$10.15+9.0%	$9.31+1.9%	$9.14+0.3%
Valuation
Market capitalization	$1.88B-50.0%	$3.76B+21.5%	$3.09B+19.3%	$2.59B+4.3%	$2.49B+17.7%
Enterprise value	$1.88B-50.0%	$3.77B+23.5%	$3.05B+18.6%	$2.57B+5.5%	$2.44B+13.8%
Price / sales	4.2×-4.5×	8.8×+1.1×	7.7×+0.5×	7.2×-0.4×	7.5×+0.6×
Price / book	7.4×-4.8×	12.2×+1.6×	10.6×+1.2×	9.4×-0.3×	9.7×+1.0×
EV / sales	4.3×-4.6×	8.8×+1.2×	7.6×+0.5×	7.1×-0.3×	7.4×+0.4×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are GeneDx Holdings's profit margins?: GeneDx Holdings (WGS) runs a 69.6% gross margin and a -14.9% operating margin, with a -17.6% net margin.
Where do GeneDx Holdings's ratios come from?: Every ratio is computed from GeneDx Holdings's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.